Status:
COMPLETED
An Observational, Retrospective, Multicenter, National Study for the Monitoring of Subjects Who Participated in the LoadET Clinical Trial
Lead Sponsor:
Pfizer
Conditions:
Ankylosing Spondylitis
Eligibility:
All Genders
18+ years
Brief Summary
Previous studies suggest that an increase in doses of weekly etanercept from 50 mg to 100 mg improves the efficacy of the treatment in patients with cutaneous psoriasis, rheumatoid arthritis, and psor...
Detailed Description
Given that this is a follow-up study of subjects who participated in the LoadET study (0881A3-102090), we have planned the inclusion of all subjects who completed said study, that is, 97 of the 108 su...
Eligibility Criteria
Inclusion
- AS patients who had previously participated in the LoadET study (0881A3-102090).
- Subjects who completed the LoadET Study.
- Patients who grant their informed consent
Exclusion
- Patients who participated in the LoadET study but who discontinued treatment and, therefore, did not complete the study.
- Patients without standard follow-up by the physician since the end of the study.
Key Trial Info
Start Date :
December 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2012
Estimated Enrollment :
85 Patients enrolled
Trial Details
Trial ID
NCT01793285
Start Date
December 1 2010
End Date
February 1 2012
Last Update
February 15 2013
Active Locations (15)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Madrid, Alcorcón, Spain, 28922
2
Pfizer Investigational Site
Sabadell, Barcelona, Spain, 08208
3
Pfizer Investigational Site
Murcia, El Palmar, Spain, 20120
4
Pfizer Investigational Site
Barcelona, Hospitalet de Llobregat, Spain, 08907